One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 10, 2009, Pages 4229-4238

  Paşca, Sergiu P ^a,b   Dronca, Eleonora ^a   Kaucsár, Tamás ^a   Crǎciun, Elena C ^a   Endreffy, Emõke ^c   Ferencz, Beatrix K ^d   Iftene, Felicia ^a   Benga, Ileana ^a   Cornean, Rodica ^a   Banerjee, Ruma ^e   Dronca, Maria ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Center for Cognitive and Neural Studies Coneural   (Romania)

^c UNIVERSITY OF SZEGED   (Hungary)

^d BABE BOLYAI UNIVERSITY   (Romania)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Autism; Methionine cycle; MTHFR; Transsulphuration; Vitamins

Indexed keywords

AMINOBUTYRIC ACID DERIVATIVE; BUTYRINE; CARBON; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ALPHA-AMINOBUTYRIC ACID;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOBUTYRIC ACIDS; CARBON; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE; HOMOCYSTEINE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; AMINOBUTYRATES;

EID: 77449158432     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00463.x     Document Type: Article

References (50)

1. Volkmar FR, Pauls D. Autism. Lancet. 2003, 362:1133-41.
2. Diagnostic and Statistical Manual-Text Revision 2000, American Psychiatric Association, 4th ed., Washington, DC, American Psychiatric Association
3. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ. 2007, 56:12-28. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, Centers for Disease Control and Prevention
4. Baird G, Simonoff E, Pickles A. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 2006, 368:210-5.
5. Gupta AR, State MW. Recent advances in the genetics of autism. Biol Psychiatry. 2007, 61:429-37.
6. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006, 29:349-58.
7. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol. 2007, 17:103-11.
8. Happe F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci. 2006, 9:1218-20.
9. Manzi B, Loizzo AL, Giana G. Autism and metabolic diseases. J Child Neurol. 2008, 23:307-14.
10. James SJ, Cutler P, Melnyk S. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004, 80:1611-7.
11. James SJ, Melnyk S, Jernigan S. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006, 141:947-56.
12. Paüsca SP, Nemes B, Vlase L. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci. 2006, 78:2244-8.
13. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res. 2006, 66:182-8.
14. Moretti P, Peters SU, Del Gaudio D. Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency. J Autism Dev Disord. 2008, 38:1170-7.
15. Boris M, Goldblatt A, Galanko J. Association of MTHFR gene variants with autism. J Am Phys Surg 2004, 9:106-8.
16. Deth R, Muratore C, Benzecry J. How environmental and genetic factors combine to cause autism: A redox/ methylation hypothesis. Neurotoxicology. 2008, 29:190-201.
17. Suh J, Walsh W, McGinnis W. Altered sulfur amino acid metabolism in immune cells of children diagnosed with autism. Am J Biochem Biotech. 2008, 4:105-13.
18. Adams M, Lucock M, Stuart J. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci Lett. 2007, 422:24-9.
19. Geier DA, Kern JK, Garver CR. A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 2009, 34:394.
20. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006, 13:171-81.
21. Stabler SP, Lindenbaum J, Savage DG. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood. 1993, 81:3404-13.
22. Stabler SP, Marcell PD, Podell ER. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest. 1988, 81:466-74.
23. Aslanidis C, Nauck M, Schmitz G. High-speed prothrombin G->A 20210 and methylenetetrahydrofolate reductase C->T 677 mutation detection using real-time fluorescence PCR and melting curves. Biotechniques. 1999, 27:8-6.
24. Moore LE, Hung R, Karami S. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer. 2008, 122:1710-5.
25. Walker DR, Thompson A, Zwaigenbaum L. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger syndrome, and autism. J Am Acad Child Adolesc Psychiatry. 2004, 43:172-80.
26. Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006, 2:R138-50.
27. Sugden C. One-carbon metabolism in psychiatric illness. Nutr Res Rev. 2006, 19:117-36.
28. Muskiet FA, Kemperman RF. Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J Nutr Biochem. 2006, 17:717-27.
29. Ahearn WH, Castine T, Nault K. An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. J Autism Dev Disord. 2001, 31:505-11.
30. Arnold GL, Hyman SL, Mooney RA. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord. 2003, 33:449-54.
31. Levy SE, Souders MC, Ittenbach RF. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry. 2007, 61:492-7.
32. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997, 78:523-6.
33. Latif A, Heinz P, Cook R. Iron deficiency in autism and Asperger syndrome. Autism. 2002, 6:103-14.
34. Fernell E, Karagiannakis A, Edman G. Aberrant amino acid transport in fibroblasts from children with autism. Neurosci Lett. 2007, 418:82-6.
35. Siva Sankar DV. Plasma levels of folates, riboflavin, vitamin B6, and ascorbate in severely disturbed children. J Autism Dev Disord. 1979, 9:73-82.
36. Adams JB, George F, Audhya T. Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements. J Altern Complement Med. 2006, 12:59-63.
37. Adams JB, Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med. 2004, 10:1033-9.
38. Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett. 2007, 28:565-73.
39. Prudova A, Albin M, Bauman Z. Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. Antioxid Redox Signal. 2007, 9:1875-81.
40. Vitvitsky V, Prudova A, Stabler S. Testosterone regulation of renal cystathionine beta-synthase: implications for sex-dependent differences in plasma homocysteine levels. Am J Physiol Renal Physiol 2007, 293:F594-600.
41. Alberti A, Pirrone P, Elia M. Sulphation deficit in " low-functioning" autistic children: a pilot study. Biol Psychiatry. 1999, 46:420-4.
42. Clarkson TW, Nordberg GF, Sager PR. Reproductive and developmental toxicity of metals. Scand J Work Environ Health. 1985, 11:145-54.
43. Nataf R, Skorupka C, Amet L. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol. 2006, 214:99-108.
44. Geier DA, Geier MR. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A. 2007, 70:1723-30.
45. Geier DA, Geier MR. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res. 2006, 10:57-64.
46. Boger-Megiddo I, Shaw DW, Friedman SD. Corpus callosum morphometrics in young children with autism spectrum disorder. J Autism Dev Disord. 2006, 36:733-9.
47. Connolly AM, Chez M, Streif EM. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry. 2006, 59:354-63.
48. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr. 2002, 22:255-82.
49. Badcock C, Crespi B. Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism. J Evol Biol. 2006, 19:1007-32.
50. Uhlhaas PJ, Singer W. What do disturbances in neural synchrony tell us about autism. Biol Psychiatry. 2007, 62:190-1.